HABER

Research code: HABER
Research name: The study is non-interventional in nature and involves the collection of data from patients with hormone receptor-positive, HER 2 negative advanced breast cancer admitted to the centre between 1 September 2020 and 31 August 2021 for first-line treatment of advanced breast cancer as part of their standard medical care. The research is a retrospective analysis of medical records.
Indication: breast cancer
Principal researcher: Ewa Chmielowska, MD, PhD